Search Results - Quanfeng Zhao

A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS) by Dan Liu, Wei Mao, Bin Hu, Xingxing Li, Quanfeng Zhao, Lin Zhang, Jing Hu

Connect to this object online.

A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy by Yang Yang, Quanfeng Zhao, Zhe Peng, Yunjiang Zhou, Miao-Miao Niu, Lin Chen, Lin Chen

Connect to this object online.

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular D... by Xiaoyan Tian, Quanfeng Zhao, Xiaohong Chen, Zhe Peng, Xiaodan Tan, Qin Wang, Lin Chen, Yang Yang

Connect to this object online.

Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data by Quanfeng Zhao, Pan Ma, Peishu Fu, Jiayu Wang, Jiayu Wang, Kejing Wang, Kejing Wang, Lin Chen, Lin Chen, Yang Yang, Yang Yang

Connect to this object online.

Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data by Quanfeng Zhao, Pan Ma, Peishu Fu, Jiayu Wang, Jiayu Wang, Kejing Wang, Kejing Wang, Lin Chen, Lin Chen, Yang Yang, Yang Yang

Connect to this object online.